Professional perspective
Clinical relevance
- Diagnosis of peri-implant health, mucositis, and peri-implantitis according to current case definitions
- Establishing individualized recall intervals and baseline examinations (probing depths, radiography) for early detection
- Patient education on the importance of consistent biofilm control on implant surfaces
- Realistic framing of titanium particles, corrosion, and hypersensitivity in response to patient questions about ‘titanium intolerance’
Osseointegration and the oxide layer
Osseointegration, a concept shaped decisively by Brånemark and colleagues since the 1960s, refers to the direct structural and functional connection between living bone and the implant surface under functional loading. A key contributor to corrosion resistance and biocompatibility is the spontaneously formed, stable titanium oxide layer, which regenerates quickly if damaged. However, an implant's clinical behavior is not determined by the oxide layer alone, but by the interplay of material composition, surface topography, surface energy and chemistry, possible contamination, implant design, and individual tissue response. If the oxide layer is damaged or destabilized by mechanical, chemical, or microbial-inflammatory influences, the tendency toward corrosion can increase.
Classification of peri-implant diseases
The 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (EFP/AAP) established consensus case criteria for peri-implant health, peri-implant mucositis, and peri-implantitis (Berglundh et al., 2018). Peri-implant health is characterized by the absence of erythema, bleeding on probing, swelling, and suppuration; it can also be present with reduced but stable bone levels. Peri-implant mucositis is characterized by bleeding on gentle probing, with strong evidence for biofilm as the etiological factor. Peri-implantitis is present when, in addition to signs of inflammation, progressive loss of supporting bone is detectable beyond what would be expected from functional loading and initial remodeling (Renvert et al., 2018). Peri-implantitis shares clinical and etiological parallels with periodontitis but is distinguished as a condition in its own right due to the absence of a periodontal ligament, differing connective tissue fiber orientation, and at times more rapid progression.
Where no prior examination or radiographic data are available, Renvert et al. (2018) consider bleeding and/or suppuration on probing, combined with probing depths of at least 6 mm and a radiographic bone level of at least 3 mm apical to the most coronal intraosseous portion of the implant, as indicative of peri-implantitis. This secondary case definition serves for classification when baseline data are missing, not as a universal threshold. A diagnostic accuracy study (Romandini et al., 2021) found high specificity but low sensitivity for this criterion relative to actual baseline data, particularly in early or incipient cases, underscoring the importance of documented baseline findings.
Titanium particles and corrosion
A comprehensive critical review (Mombelli, Hashim, Cionca, 2018) synthesizes the evidence on titanium particles, biocorrosion, and implant complications. Titanium particles can be released from various sources before, during, and after implantation, such as placement itself, mechanical wear, or contact with chemical substances, and are detected around both healthy and diseased implants, though at higher concentrations in diseased tissue. The evidence points more toward a possible bidirectional interaction than toward clearly established one-directional causality: inflammation and bacterial activity can promote corrosion through a falling local pH, while released particles can simultaneously exhibit pro-inflammatory properties. Overall, an association exists between biocorrosion, titanium particles, and biological implant complications, but sufficiently established one-directional causality does not.
Titanium hypersensitivity
Hypersensitivity reactions to titanium-based implant materials have been described but are considered rare and diagnostically difficult to attribute with certainty. The German S3 guideline on titanium hypersensitivity in implant dentistry (Müller-Heupt et al., 2022) notes that available diagnostic procedures, such as patch testing or the lymphocyte transformation test, show inconsistent results regarding reliability and validity. A standardized, clinically reliable predictive test procedure is not currently available; positive test results do not reliably predict whether an implant will cause clinical symptoms. Where clinical suspicion is well founded, the guideline recommends structured specialist assessment.
Prevention and therapy
The EFP S3 guideline on the prevention and treatment of peri-implant diseases (Herrera et al., 2023) emphasizes interdisciplinary approaches to preventing initial occurrence and recurrence, including pre-implant risk assessment, periodontal pretreatment where periodontitis is present, and structured supportive peri-implant therapy following completion of active treatment.
What current evidence supports
- The principle of osseointegration and the long-standing clinical track record of titanium-based implants
- The biofilm-associated origin of peri-implant diseases, with consensus case definitions for peri-implant health, mucositis, and peri-implantitis
- An association, though not established one-directional causality, between biocorrosion, titanium particles, and biological implant complications
Why this matters
Patients increasingly ask about ‘titanium intolerance’ in the context of broader wellness narratives about metal toxicity. Being able to explain, with appropriate nuance, that hypersensitivity is real but rare, that no validated predictive test currently exists, and that titanium particles are also found around healthy implants, helps set realistic expectations without dismissing genuine clinical concerns or over-medicalizing normal findings.
What the data currently doesn't show
- No established one-directional causality between titanium particles and the development of peri-implantitis
- No sufficiently standardized, clinically predictive test procedures for titanium hypersensitivity
- No single bone-loss threshold that determines diagnosis or prognosis for all implants independent of baseline level, healing-related remodeling, and longitudinal data; diagnosis requires comparison against baseline imaging or defined surrogate criteria
Evidence summary
Berglundh, Armitage, Araujo, et al. (2018): Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop. Journal of Clinical Periodontology, 45(Suppl 20), S286-S291.
Renvert, Persson, Pirih, Camargo (2018): Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. Journal of Clinical Periodontology, 45(Suppl 20), S278-S285.
Romandini, Berglundh, Derks, Sanz, Berglundh (2021): Diagnosis of peri-implantitis in the absence of baseline data: A diagnostic accuracy study. Clinical Oral Implants Research, 32(3), 297-313. Found high specificity but low sensitivity of the WWP 2017 secondary criteria relative to actual baseline data.
Herrera, Berglundh, Schwarz, et al. (2023): Prevention and treatment of peri-implant diseases, the EFP S3 level clinical practice guideline. Journal of Clinical Periodontology, 50(Suppl 26), 4-76.
Mombelli, Hashim, Cionca (2018): What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review. Clinical Oral Implants Research, 29(Suppl 18), 37-53.
Müller-Heupt, Schiegnitz, Kaya, Jacobi-Gresser, Kämmerer, Al-Nawas (2022): The German S3 guideline on titanium hypersensitivity in implant dentistry: consensus statements and recommendations. International Journal of Implant Dentistry, 8, 51.